TY - JOUR AU - Noguchi, Shingo AU - Yatera, Kazuhiro PY - 2018 TI - Efficacy and immune activation of ipilimumab in early-stage lung cancer patients JF - Journal of Thoracic Disease; Vol 10, Supplement 17 (June 20, 2018): Journal of Thoracic Disease Y2 - 2018 KW - N2 - Immune checkpoint inhibitors, such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) antibody and programmed death-1 (PD-1) antibody, improve the prognosis in several types of cancer patients, and they modulate the effector T-cell activation, proliferation and function (1). UR - https://jtd.amegroups.org/article/view/21731